PT-141
$30.00
PT-141 (bremelanotide) is a synthetic peptide that stimulates melanocortin receptors in the brain to increase sexual desire. Unlike drugs like Viagra that boost blood flow, PT-141 acts on the nervous system. It is FDA-approved under the brand name Vyleesi to treat hypoactive sexual desire disorder in premenopausal women.
How PT-141 Works
- Central Action: Binds to melanocortin receptors (mainly MC4R) in the hypothalamus to trigger sexual motivation.
- Desire vs. Mechanics: Functions as the brain's "ignition" for libido rather than just managing physical blood flow.
- Administration: The FDA-approved version uses a subcutaneous auto-injector roughly 45 minutes prior to intimacy.